Amylyx Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100001351941

Total reported 2019–2025

$5.09M

#700 of 2,960 reporting companies — 0% of all reported industry payments

$652K in general payments across 2,522 records, plus $4.44M in research funding across 630 records.

How it breaks down

General payments $651,880

Research funding $4,439,254

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.